Retina Gallery ~ Full Sized Retina Images

Library of Free, Non-Copyrighted Retina Images and Videos

Wähle Sprache:



25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy

crvo_mabr_050415_01.png
CRVO 25 year old man - Heterozygous Factor V Leiden557 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_02.png
CRVO 25 year old man - Heterozygous Factor V Leiden442 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_03.png
CRVO 25 year old man - Heterozygous Factor V Leiden496 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_05.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden431 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_07.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden484 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_08.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden445 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_09.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden530 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_10.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden449 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_06.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden447 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_04.png
CRVO 25 year old man - Heterozygous Factor V Leiden440 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_11.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden434 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_12.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden433 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_14.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden449 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_13.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden452 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_15.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden468 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_16.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden438 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_17.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden432 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_18.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden476 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_19.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden421 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_20.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden402 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_21.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden424 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_22.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden462 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_23.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden456 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_25.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden493 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
crvo_mabr_050415_24.jpg
CRVO 25 year old man - Heterozygous Factor V Leiden427 x angesehen20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.00000
(0 Bewertungen)
     
25 Dateien auf 1 Seite(n)

25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy